IINNW Inspira Technologies OXY B.H.N. Ltd
Price Chart
Executive Summary
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100 extracorporeal blood circulation systems, blood circulation systems. The order follows a multi-patient clinical evaluation at NYU Langone and is scheduled for immediate fulfillment.
Actionable Insight
The $580,000 purchase order from a order from a top-tier academic medical center provides a key commercial reference, supporting Inspira's ongoing strategic process. Traders should watch for potential partnership, licensing, or monetization announcements related to the ART100 platform, which could unlock further value. With a market cap of only $2M, this order represents meaningful revenue relative to scale.
Key Facts
- Inspira received a $580,000 purchase order from NYU Langone Hospital for the ART100 system.
- The order was placed through Inspira received follows a multi-patient clinical evaluation involving more than 30 patients.
- The ART100 system is FDA-cleared for cardiopulmonary bypass procedures.
- The systems are scheduled for immediate fulfillment.
- Inspira disclosed it is advancing an 'active strategic process' involving multiple counterparties regarding the ART100 platform and additional medical assets.
Financial Impact
$580,000 commercial purchase order from NYU Langone Hospital.
Risk Factors
- The order is a single, modest transaction that may not extrapolate to scale.
- The company is actively seeking to monetize ART100 and other medical assets—there is no guarantee of a favorable transaction.
- No financial details or profitability impact disclosed; historical 20-F shows pre-revenue stage.
- Warrant ticker IINNW is highly speculative, volatile and prone to large price swings irrespective of news quality.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001185185-26-001890 |
| Document: iinnex99-1.htm | 0001185185-26-001890 |
| Document: 0001185185-26-001890-index-headers.html | 0001185185-26-001890 |
| Document: 0001185185-26-001890-index.html | 0001185185-26-001890 |
| Document: 0001185185-26-001890.txt | 0001185185-26-001890 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
21d ago
|
6-K
| $0.1420 $0.2600 | ▲ +83.10% | ▲ +80.85% | $0.2200 (+54.93%) |
|
May 18, 2026
22d ago
|
6-K
| $0.0830 $0.2600 | ▲ +213.25% | ▲ +211.63% | $0.2200 (+165.06%) |
|
Apr 16, 2026
7w ago
|
6-K
| $0.1100 $0.0700 | ▼ −36.36% | ▼ −37.35% | $0.2200 (+100.00%) |
|
Apr 16, 2026
7w ago
|
6-K
| $0.1100 $0.0700 | ▼ −36.36% | ▼ −37.35% | $0.2200 (+100.00%) |
|
Apr 15, 2026
7w ago
|
6-K
| $0.1100 $0.0700 | ▼ −36.36% | ▼ −37.35% | $0.2200 (+100.00%) |
|
Apr 14, 2026
8w ago
|
6-K
| $0.0720 $0.0710 | ▼ −1.39% | ▼ −2.78% | $0.2200 (+205.56%) |
|
Apr 13, 2026
8w ago
|
6-K
| $0.0600 $0.0980 | ▲ +63.33% | ▲ +60.04% | $0.2200 (+266.67%) |
|
Apr 6, 2026
9w ago
|
6-K
| $0.1000 $0.0600 | ▼ −40.00% | ▼ −44.13% | $0.2200 (+120.00%) |
|
Apr 6, 2026
9w ago
|
6-K
| $0.1000 $0.0600 | ▼ −40.00% | ▼ −44.13% | $0.2200 (+120.00%) |
|
Mar 31, 2026
10w ago
|
6-K
| $0.0800 $0.1000 | ▲ +25.00% | ▲ +21.06% | $0.2200 (+175.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access